Home » Newsletters » BioWorld Asia

BioWorld Asia

July 12, 2000

View Archived Issues

Arrow Completes #11M Round For Antimicrobial Programs

EU Patent Plan Would Reduce Costs, Encourage Innovation

Drug-Resistant HIV Strains Arise Prior To Start Of Drug Treatment

Ontario Invests In Three Centers, Plans To Become Biotech Hub

Brandys Steps Down At Genset; Director Assumes Top Positions

British Biotech Changes Focus, Seeks To Move Past Marimastat

Roche, Atugen Collaborate To Study Gene Function In Vivo

UK Genetics Commission Plans Open Discussion On Principles

Israeli Biotech Companies Continue Moving Forward

Australian Investors Launch Biotechnology Venture Fund

Lion Bioscience Seeks $191M In IPO On Nasdaq, Neuer Markt

Prodi Recognizes EU Need To Restore Confidence In Biotech

EPO Upholds CAT Patent On Phage Display Of Antibodies

NicOx Gets Positive Results In Early Dermatology Trial

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...